Follows pregnant women with ulcerative colitis who take ozanimod
Observes safety outcomes in pregnant women taking ozanimod for ulcerative colitis, and their babies.
Plain-language title generated from the registry record
Registry title: A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Key facts
- Where
- Wilmington, United StatesSee the site
Where in United States
- PPD Virtual - PPD - USWilmington, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Bristol-Myers Squibb
- Trial code
- NCT05953402
- Record updated
- 15 June 2026
- Original description
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.Read full original descriptionShow less
ZEPOSIA® (Ozanimod) Ulcerative Colitis Pregnancy Registry: a Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women With Ulcerative Colitis and Their Offspring
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
Inclusion: Currently or recently pregnant; Diagnosis of UC; Resident of country where ozanimod is prescribed for the treatment of UC.
Exclusion: Exposure to other S1P therapies at any time during pregnancy; Other protocol-defined eligibility criteria apply.